S.-L. Tseng, T.-K. Yang / Tetrahedron: Asymmetry 16 (2005) 773–782
779
5.10. (S)-(3R,4S)-2,5-Dimethyl-4-morpholinohexan-3-yl
ethanethioate, 6c
127.79, 142.88 (Ph); IR (neat): 3425, 3027, 2958, 2874,
2803.1671, 1492 cmꢀ1; Anal. Calcd for C15H23NO: C,
77.21; H, 9.93; N, 6.00. Found: C, 77.11; H, 9.73; N,
6.23; HRMS (FAB): m/z calcd for C15H23NO MH+:
234.1858; found: 234.1865.
According to the general procedure, to 5c (4.0 mmol,
0.8 g) and Et3N (12 mmol, 1.8 mL) in 30 mL anhydrous
CH2Cl2 at 0 ꢁC was added MsCl (8 mmol, 0.62 mL).
The resulting solution was stirred for 1 h at 0 ꢁC, after
which TLC analysis of the reaction mixture indicated
the completion of reaction, then CH2Cl2 was removed
in vacuum. To the residue were added benzene
(30 mL), NEt3 (12 mmol, 1.8 mL), and thioacetic acid
(8 mmol, 0.57 mL) then heated to reflux for 8 h and
monitoring the completion of reaction by TLC. After
removal of solvent, the residued oil was purified
through column chromatography (eluent: n-hexane/
NEt3 = 100:1) on silica gel to afford 6c (0.72 g, 66%) as
5.13. (S)-(1R,2S)-3-Methyl-1-phenyl-2-(pyrrolidin-1-
yl)butyl ethanethioate, 6d
According to the general procedure, 6d (62%) was ob-
25
tained as a colorless oil; ½aꢁ ¼ ꢀ240:8 (c 1.02, CHCl3);
D
1H NMR (400 MHz, CDCl3) d 0.90 (d, J = 6.8 Hz, 3H,
CCH3), 0.99 (d, J = 6.4 Hz, 3H, CCH3), 1.45–1.55 (m,
4H, (CH2)2), 1.92–2.04 (m, 1H, CH(CH3)2), 2.26 (s,
3H, SCOCH3), 2.60–2.69 (m, 4H, NCH2), 2.97 (dd,
J = 6.4, 6.0 Hz, 1H, NCH), 4.99 (d, J = 6.4 Hz, 1H,
SCH), 7.14–7.41 (m, 5H, ArH); 13C NMR (100 MHz,
CDCl3) d 19.82, 21.62, 24.31, 30.57, 30.59, 49.69,
50.42, 69.33, 126.73, 127.86, 128.70, 141.80 (Ph),
23
D
1
a light red oil; ½aꢁ ¼ ꢀ10:6 (c 2.0, CHCl3); H NMR
(400 MHz, CDCl3) d 0.83 (d, J = 6.4 Hz, 3H, CMe),
0.90 (d, J = 4.8 Hz, 3H, CMe), 0.91 (d, J = 6.4 Hz, 3H,
CMe), 0.92 (d, J = 4.8 Hz, 3H, CMe), 2.00–2.18 (m,
2H, CHMe2), 2.30 (s, 3H, COMe), 2.38 (dd, J = 6.4,
4.0 Hz, 1H, CHN), 2.50–2.2.60 (m, 2H, CH2N), 2.65–
2.2.75 (m, 2H, CH2N), 3.60 (t, J = 4.0 Hz, OCH2, 4H),
3.78 (dd, J = 5.6, 4.0 Hz, 1H, CHS); 13C NMR
(100 MHz, CDCl3) d 18.10, 20.58, 20.86, 21.00, 29.43,
29.51, 30.54, 49.65, 50.01, 67.46, 69.68, 194.66; IR (neat)
2960, 2852, 2814, 1691, 1459, 1359, 1290 cmꢀ1; Anal.
Calcd for C14H27NO2S: C, 61.50; H, 9.95; N, 5.12.
Found: C, 61.55; H, 9.90; N, 5.18; HRMS (FAB): m/z
calcd for C14H27NO2S MH+: 274.1840; found: 274.1842.
194.60 (SCOCH3); IR (neat): 2959, 1690, 1133 cmꢀ1
;
HRMS (FAB): m/z calcd for C17H25NOS MH+:
292.1735; found: 292.1733.
5.14. (1R,2S)-3-Methyl-1-phenyl-2-(pyrrolidin-1-yl)-
butane-1-thiol, 7d
According to the reduced procedure, 7d (90%) was ob-
25
tained as a colorless oil; ½aꢁ ¼ ꢀ489:0 (c 1.0, CHCl3);
D
1H NMR (400 MHz, CDCl3) d 0.95 (d, J = 6.8 Hz,
3H, CHCH3), 0.99 (d, J = 6.8 Hz, 3H, CCH3), 1.37–
1.48 (m, 4H, (CH2)2), 2.06–2.15 (m, 1H, CH(CH3)2),
2.54–2.70 (m, 4H, NCH2), 3.00 (dd, J = 5.2, 7.6 Hz,
1H, NCH), 4.30 (d, J = 7.6 Hz, 1H, SCH), 7.12–7.40
(m, 5H, ArH); 13C NMR (100 MHz, CDCl3) d 18.95,
21.67, 24.46, 30.42, 50.60, 70.03, 77.20, 126.73, 127.9,
128.1, 144.57 (Ph); HRMS (FAB): m/z calcd for
C15H23NS MH+: 250.1629; found: 250.1633.
5.11. (3R,4S)-2,5-Dimethyl-4-morpholinohexane-3-thiol,
7c
According to the reduced procedure 7c (92%) was ob-
22
tained as a colorless oil; ½aꢁ ¼ ꢀ14:4 (c 1.7, CHCl3);
D
1H NMR (400 MHz, CDCl3) d 0.90 (d, J = 6.4 Hz,
3H, CH3), 1.01 (d, J = 4.8 Hz, 3H, CMe), 1.01 (d,
J = 6.4 Hz, 3H, CMe), 1.02 (d, J = 4.8 Hz, 3H, CMe),
2.07–2.20 (m, 1H, CHMe2), 2.20–2.32 (m, 1H, CHMe2),
2.26–2.35 (m, 1H, CHN), 2.58–2.73 (m, 4H, NCH2),
2.98 (td, J = 8.0, 4.0 Hz, 1H, CHS), 3.62 (t, J = 4.4 Hz,
4H, CH2O); 13C NMR (100 MHz, CDCl3) d 16.83,
20.68, 21.72, 21.79, 28.73, 29.66, 29.93, 47.17, 50.64,
67.67, 71.52; IR (neat) 2958, 2929, 2852, 2811, 1458,
1374, 1290 cmꢀ1; Anal. Calcd for C12H25NOS: C,
62.29; H, 10.89; N, 6.05. Found: C, 62.30; H, 10.84;
N, 6.10; HRMS (FAB): m/z calcd for C12H25NOS
MH+: 223.1735; found: 223.1736.
5.15. (1R,2S)-3-Methyl-1-phenyl-2-(piperidin-1-yl)butan-
1-ol, 5e
According to the N-alkylation procedure, 5e (88%) was
25
obtained as a colorless viscous oil; ½aꢁ ¼ ꢀ21:6 (c 1.0,
D
CHCl3); 1H NMR (400 MHz, CDCl3) d 0.97 (d,
J = 3.0 Hz, 3H, CH3), 1.08 (d, J = 3.0 Hz, 3H, CH3),
1.36–1.45 (m, 6H, (CH2)2CH2(CH2)), 1.70–1.82 (m,
1H, CHMe2), 2.35–2.45 (m, 5H, NCH2), 4.78 (d,
J = 4.4 Hz, 1H, CHOH), 7.15–7.42 (m, 5H, ArH); 13C
(100 MHz, CDCl3) d 21.95, 22.45, 24.73, 27.13, 28.02,
52.87, 70.30, 77.32, 126.12, 126.83, 127.67, 142.86 (Ph);
IR (neat): 3441, 2930, 2852, 2804, 1493 cmꢀ1; Anal.
Calcd for C16H25NO: C, 77.68; H, 10.19; N, 5.66.
Found: C, 77.95; H, 10.18; N, 5.75; HRMS (FAB): m/z
calcd for C16H25NO MH+: 248.2014; found: 248.2011.
5.12. (1R,2S)-3-Methyl-1-phenyl-2-(pyrrolidin-1-yl)-
butan-1-ol, 5d
According to N-alkylation procedure 5d (82%) was ob-
25
tained as a colorless viscous oil; ½aꢁ ¼ ꢀ41:3 (c 1.38,
D
CHCl3); 1H NMR (400 MHz, CDCl3) d 0.80 (d,
J = 6.8 Hz, 3H, CCH3), 0.96 (d, J = 6.8 Hz, 3H,
CCH3), 1.62–1.70 (m, 4H, (CH2)2), 1.72–1.82 (m, 1H,
CH(CH3)2), 2.54 (dd, J = 4.4, 8.0 Hz, 1H, NCH),
2.57–2.64 (m, 2H, NCH2), 2.68–2.74 (m, 2H, NCH2),
4.92 (d, J = 4.4 Hz, 1H, CHO), 7.14–7.34 (m, 5H,
ArH); 13C NMR (100 MHz, CDCl3) d 20.28, 21.81,
23.78, 27.88, 51.47, 72.29, 72.51, 126.08, 126.62,
5.16. (S)-(1R,2S)-3-Methyl-1-phenyl-2-(piperidin-1-
yl)butyl ethanethioate, 6e
According to the general procedure 6e (62%) was ob-
25
tained as a light yellow oil; ½aꢁ ¼ ꢀ172:1 (c 1, CHCl3);
D
1H (400 MHz, CDCl3) d 0.96 (d, J = 2.0 Hz, 3H, CCH3),
1.06 (d, J = 4.0 Hz, 3H, CHCH3), 1.31–1.37 (m, 6H,
CH2(CH2)2), 1.98–2.03 (m, 1H, CH(CH3)2), 2.26 (s,